Inhalation April 2026 9
Joanne Kilgour, PhD, is Chair of
the Association of Inhalation Tox-
icologists (AIT) and a Consultant
Toxicologist at Mereside Toxicol-
ogy Consulting Ltd, Tel: +44 7760
194839, jo.kilgour@apconix.com.
Charles J. Knill , PhD, is Co-
Membership Secretary & Admin
of the Association of Inhalation Tox-
icologists (AIT) and an Independent
Scientific Consultant based in Liv-
erpool, UK, cjk16309@yahoo.co.uk.
• In vitro testing and NAMs in
inhalation toxicology—publi-
cations pending in the Special
Edition.
Get involved
We encourage you to visit the
AIT website and LinkedIn page to
find opportunities to engage with
members and attend a future con-
ference. Please contact the AIT at:
aitoxicology@gmail.com.
Membership
Attendance at an AIT conference
conveys membership for a period
of three years and is renewable
with each conference attendance.
e AIT currently has more than
180 members. ey have access to
an archive of useful information
(via the website), including webi-
nars, conference slides, posters,
photos, annual general meeting
(AGM) documents and various
useful publications.
Publications
A list of published AIT papers can
be found on the website. In addi-
tion, the AIT is currently collabo-
rating with Frontiers in Toxicology
to publish a special edition of papers
based on themes explored at the
2025 AIT conference: www.fron
tiersin.org/research-topics/71870/
inhalation-toxicology-trailblazers-
charting-a-new-path-to-improve-
nams-for-evidence- integration.
Workstreams
e AIT has several workstreams
led by committee members, which
aim to increase the AIT's influence
(one of our goals) and potentially
add to the list of publications con-
tributed to or delivered by the
AIT. ese include:
• Regulatory harmonization with
respect to the calculation of
safety margins for inhaled tox-
icity studies. Members of this
team have been instrumental in
helping organize a Reagan-Udall
Foundation workshop titled,
"Advancing Drug Develop-
ment by Reducing Reliance on
Animal Testing—Case Exam-
ple: Preclinical Animal Models
in Lung Toxicology" scheduled
for February 2026: reaganudall.
org/news-and-events/events/
advancing-drug-development-
r e d u c i n g - r e l i a n c e - a n i m a l -
testing.
• Best practice regarding varying
of exposure time versus concen-
tration to achieve desired doses
in inhaled toxicity studies.